Clinical Trial Update: Metabolic Modulation as Treatment in Acute Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metabolic modulation as a treatment for acute heart failure was terminated. No results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: University of Aarhus | Conditions: Acute Heart Failure | Phase 2 | Status: TERMINATED